Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Brain Diseases × Genitourinary × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

CNS 4 Thoracic 2 Genitourinary 1 Breast 1

Conditions

Prostatic Neoplasms 1098 Urinary Bladder Neoplasms 342 Carcinoma, Renal Cell 303 Kidney Neoplasms 182 Neoplasms 139 Breast Neoplasms 130 Lung Neoplasms 89 Carcinoma, Transitional Cell 83 Colorectal Neoplasms 67 Testicular Neoplasms 66 Ovarian Neoplasms 56 Melanoma 53 Pancreatic Neoplasms 50 Carcinoma, Non-Small-Cell Lung 46 Colonic Neoplasms 42 Stomach Neoplasms 39 Neoplasm Metastasis 39 Head and Neck Neoplasms 39 Disease 38 Non-Muscle Invasive Bladder Neoplasms 36 Esophageal Neoplasms 34 Uterine Cervical Neoplasms 33 Prostatic Hyperplasia 33 Wilms Tumor 32 Liver Neoplasms 32 Multiple Myeloma 30 Sarcoma 28 Adenocarcinoma 28 Urologic Neoplasms 27 Recurrence 27

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04290611 2023-04-13

VENDY

Groupe Hospitalier Pitie-Salpetriere

500,000 enrolled

Brain Diseases, Epilepsy, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡